Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - SKINOVATION PHARMACEUTICAL INC | skin0324form10kexh31_1.htm |
| 10-K - FORM 10-K - SKINOVATION PHARMACEUTICAL INC | skin0324form10k.htm |
| EX-31.2 - EXHIBIT 31.2 - SKINOVATION PHARMACEUTICAL INC | skin0324form10kexh31_2.htm |
Exhibit 32.1
SKINOVATION PHARMACEUTICAL INCORPORATED
CERTIFICATION OF PERIODIC REPORT
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
18 U.S.C. Section 1350
The undersigned executive officer of Skinovation Pharmaceutical Incorporated certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
| • | the annual report on Form 10-K of the Company for the year ended December 31, 2020, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| • | the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: March 29, 2021
|
/s/ Hugo Rodier Hugo Rodier Principal Executive Officer Principal Financial Officer |